
### [MONDO:0004949](http://purl.obolibrary.org/obo/MONDO_0004949)
**Label:** neoplasm of mature b-cells

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0007190](http://purl.obolibrary.org/obo/MONDO_0007190) (leukemia, chronic lymphocytic, susceptibility to, 2), [MONDO:0018689](http://purl.obolibrary.org/obo/MONDO_0018689) (plasma cell leukemia), [MONDO:0009693](http://purl.obolibrary.org/obo/MONDO_0009693) (multiple myeloma), [MONDO:0017596](http://purl.obolibrary.org/obo/MONDO_0017596) (diffuse large b-cell lymphoma of the central nervous system), [MONDO:0018225](http://purl.obolibrary.org/obo/MONDO_0018225) (ALK-positive large b-cell lymphoma), [MONDO:0017597](http://purl.obolibrary.org/obo/MONDO_0017597) (T-cell/histiocyte rich large b cell lymphoma), [MONDO:0020323](http://purl.obolibrary.org/obo/MONDO_0020323) (primary mediastinal large b-cell lymphoma), [MONDO:0020324](http://purl.obolibrary.org/obo/MONDO_0020324) (intravascular large b-cell lymphoma), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0017817](http://purl.obolibrary.org/obo/MONDO_0017817) (primary localized amyloidosis), [MONDO:0017816](http://purl.obolibrary.org/obo/MONDO_0017816) (primary systemic amyloidosis), [MONDO:0018905](http://purl.obolibrary.org/obo/MONDO_0018905) (diffuse large B-cell lymphoma), [MONDO:0018906](http://purl.obolibrary.org/obo/MONDO_0018906) (follicular lymphoma), [MONDO:0017346](http://purl.obolibrary.org/obo/MONDO_0017346) (Epstein-Barr virus-positive diffuse large b-cell lymphoma of the elderly), [MONDO:0019469](http://purl.obolibrary.org/obo/MONDO_0019469) (T-cell large granular lymphocyte leukemia), [MONDO:0017601](http://purl.obolibrary.org/obo/MONDO_0017601) (diffuse large b-cell lymphoma with chronic inflammation), [MONDO:0015043](http://purl.obolibrary.org/obo/MONDO_0015043) (extramedullary soft tissue plasmacytoma), [MONDO:0019466](http://purl.obolibrary.org/obo/MONDO_0019466) (lymphomatoid granulomatosis), [MONDO:0013088](http://purl.obolibrary.org/obo/MONDO_0013088) (FL1), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0015042](http://purl.obolibrary.org/obo/MONDO_0015042) (primary plasmacytoma of the bone), [MONDO:0005615](http://purl.obolibrary.org/obo/MONDO_0005615) (plasmacytoma), [MONDO:0007897](http://purl.obolibrary.org/obo/MONDO_0007897) (leukemia, chronic lymphocytic), [MONDO:0012936](http://purl.obolibrary.org/obo/MONDO_0012936) (leukemia, chronic lymphocytic, susceptibility to, 5), [MONDO:0007650](http://purl.obolibrary.org/obo/MONDO_0007650) (malt lymphoma), [MONDO:0006383](http://purl.obolibrary.org/obo/MONDO_0006383) (primary cutaneous diffuse large b-cell lymphoma, leg type), [MONDO:0012935](http://purl.obolibrary.org/obo/MONDO_0012935) (leukemia, chronic lymphocytic, susceptibility to, 4), [MONDO:0012318](http://purl.obolibrary.org/obo/MONDO_0012318) (leukemia, chronic lymphocytic, susceptibility to, 1), [MONDO:0012934](http://purl.obolibrary.org/obo/MONDO_0012934) (leukemia, chronic lymphocytic, susceptibility to, 3), 

**Corr. equiv. classes:** [Orphanet:454714](http://www.orpha.net/ORDO/Orphanet_454714), [Orphanet:300849](http://www.orpha.net/ORDO/Orphanet_300849), [Orphanet:300888](http://www.orpha.net/ORDO/Orphanet_300888), [Orphanet:86855](http://www.orpha.net/ORDO/Orphanet_86855), [Orphanet:86872](http://www.orpha.net/ORDO/Orphanet_86872), [Orphanet:178544](http://www.orpha.net/ORDO/Orphanet_178544), [OMIM:151400](http://purl.obolibrary.org/obo/OMIM_151400), [Orphanet:85443](http://www.orpha.net/ORDO/Orphanet_85443), [Orphanet:289661](http://www.orpha.net/ORDO/Orphanet_289661), [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [OMIM:613024](http://purl.obolibrary.org/obo/OMIM_613024), [Orphanet:98838](http://www.orpha.net/ORDO/Orphanet_98838), [Orphanet:98839](http://www.orpha.net/ORDO/Orphanet_98839), [OMIM:612558](http://purl.obolibrary.org/obo/OMIM_612558), [OMIM:612557](http://purl.obolibrary.org/obo/OMIM_612557), [OMIM:609630](http://purl.obolibrary.org/obo/OMIM_609630), [OMIM:254500](http://purl.obolibrary.org/obo/OMIM_254500), [OMIM:612559](http://purl.obolibrary.org/obo/OMIM_612559), [OMIM:109543](http://purl.obolibrary.org/obo/OMIM_109543), [OMIM:137245](http://purl.obolibrary.org/obo/OMIM_137245), [Orphanet:86869](http://www.orpha.net/ORDO/Orphanet_86869), [Orphanet:300857](http://www.orpha.net/ORDO/Orphanet_300857), [Orphanet:100021](http://www.orpha.net/ORDO/Orphanet_100021), [Orphanet:364043](http://www.orpha.net/ORDO/Orphanet_364043), [Orphanet:100022](http://www.orpha.net/ORDO/Orphanet_100022), [Orphanet:52417](http://www.orpha.net/ORDO/Orphanet_52417), [Orphanet:29073](http://www.orpha.net/ORDO/Orphanet_29073), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [Orphanet:314709](http://www.orpha.net/ORDO/Orphanet_314709), [Orphanet:314701](http://www.orpha.net/ORDO/Orphanet_314701), [Orphanet:544](http://www.orpha.net/ORDO/Orphanet_544), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [Orphanet:545](http://www.orpha.net/ORDO/Orphanet_545), 

**Class expressions from DL-Learner:**

- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 25.31%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 25.24%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 25.24%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 25.24%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 25.24%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 25.24%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 25.24%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 23.95%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 23.71%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 21.01%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 20.50%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 20.25%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 18.36%
- Thing 18.35%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 18.35%


